Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × IFL protocol × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 21 Neoplasm Metastasis 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Ras-mutated Metastatic Colorectal Cancer 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian Neoplasms 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Esophageal Squamous Cell Carcinoma 1

Interventions

Nivolumab 6 Ipilimumab 5 Cisplatin 5 atezolizumab 4 Carboplatin 4 Etoposide 3 gallium Ga 68 dotatate 2 dostarlimab 2 Temozolomide 2 Positron Emission Tomography Computed Tomography 2 Paclitaxel 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 Drug Therapy 2 Disulfides 2 zimberelimab 1 tivozanib 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 niraparib 1 lutetium Lu 177 dotatate 1 iadademstat 1 durvalumab 1 cabozantinib 1 budigalimab 1 berzosertib 1 belinostat 1 Topotecan 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02820857 2025-09-03

BEVANEC

Hospices Civils de Lyon

Phase 2 Completed

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡